CSBR Financial Facts
Total operating revenue: 3.67MSales and marketing: 925K
See Full Income Statement
Accounts receivable: 1.63M
Accumulated deficit: -65.01M
See Full Balance Sheet
Champions Oncology, Inc. (CSBR) Earnings
|
Expand Research on CSBR
| Next EPS Date | 7/16/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +1,054.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.2% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
7/16/26  |
Q426 | N/A | -$0.05 | N/A | N/A | $12.89M | N/A | N/A | N/A | ||
| 3/12/26 | Q326 | $0.04 | $0.08 | -$0.04 | $16.6M | $16.43M | N/A |  | | Details | |
| 12/15/25 |
Q226 | N/A | $0.01 | N/A | N/A | $14.04M | N/A | N/A | N/A | ||
| 9/15/25 | Q126 | $0.02 | -$0.01 | +$0.03 | $14M | $14.7M | N/A | | | Details | |
| 9/10/25 |
Q126 | N/A | $0.06 | N/A | N/A | $14.7M | N/A | N/A | N/A | ||
| 7/23/25 |
Q425 | N/A | $0.06 | N/A | N/A | $15.7M | N/A | N/A | N/A | ||
| 7/21/25 |
Q425 | N/A | $0.06 | N/A | N/A | $15.7M | N/A | N/A | N/A | ||
| 7/17/25 |
Q425 | N/A | $0.06 | N/A | N/A | $15.7M | N/A | N/A | N/A |
